Kistler-Tiffany Companies’s Inovio Pharmaceuticals INO Stock Holding History

Kistler-Tiffany Companies’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$163	Hold	30	–	–	﹤0.01%	880
2023 Q1	$300	Hold	30	–	–	﹤0.01%	778
2022 Q4	$569	Hold	30	–	–	﹤0.01%	766
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	753
2022 Q2	$1K	Hold	30	–	–	﹤0.01%	736
2022 Q1	$1K	Hold	30	–	–	﹤0.01%	725
2021 Q4	$2K	Hold	30	–	–	﹤0.01%	678
2021 Q3	$3K	Hold	30	–	–	﹤0.01%	658
2021 Q2	$3K	Hold	30	–	–	﹤0.01%	636
2021 Q1	$3K	Hold	30	–	–	﹤0.01%	594
2020 Q4	$3K	Hold	30	–	–	﹤0.01%	577
2020 Q3	$4K	Hold	30	–	–	﹤0.01%	566
2020 Q2	$10K	Buy	+30	New	+$4.82K	﹤0.01%	444

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Kistler-Tiffany Companies's INO Position: Q2 2023 in Review

Kistler-Tiffany Companies held its Inovio Pharmaceuticals (INO) position steady in Q2 2023 at 30 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Kistler-Tiffany Companies first reported a position in INO in Q2 2020 and has held it in 13 quarters since. The position peaked at $10K in Q2 2020. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

Kistler-Tiffany Companies held 30 shares of Inovio Pharmaceuticals worth $163 as of Q2 2023.
Kistler-Tiffany Companies left its Inovio Pharmaceuticals share count unchanged in Q2 2023.
Inovio Pharmaceuticals made up ﹤0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #880 holding.
Kistler-Tiffany Companies first reported a position in Inovio Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
Kistler-Tiffany Companies's Inovio Pharmaceuticals position peaked at $10K in Q2 2020.
133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.